Announcements
- Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
- Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
- Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
- Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
- Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
More ▼
Key statistics
On Friday, Conduit Pharmaceuticals Inc (ZK7:BER) closed at 2.72, 4.50% above its 52-week low of 2.60, set on May 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.71 |
---|---|
High | 2.73 |
Low | 2.71 |
Bid | 2.53 |
Offer | 2.84 |
Previous close | 2.77 |
Average volume | 0.00 |
---|---|
Shares outstanding | 73.83m |
Free float | 9.85m |
P/E (TTM) | -- |
Market cap | 219.27m USD |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 17 2024 17:35 BST.
More ▼